Optimizing Training in Severe Post-Stroke Walking Impairment (BLT2b)

September 11, 2023 updated by: Oluwole Awosika, University of Cincinnati
Difficulty walking is common after a stroke. Although physical rehabilitation helps a little with the improvement of walking ability, recovery is usually incomplete. The purpose of this study is to explore how two different treadmill training approaches influence walking speed, symmetry, and balance in people with chronic severe stroke-related walking impairment. The two approaches involve either forward or backwards treadmill training. This study will look at changes in walking performance and balance, before and after training. This study may lead to more efficient methods for improving walking performance and balance after stroke.

Study Overview

Detailed Description

Severe walking impairment after stroke is defined as the inability to walk faster than 0.4 meters per second and impacts nearly twenty-five percent of chronic stroke survivors. Walking speed is a key determiner of community independence, and stroke survivors classified as "severe" are more often symptomatically home-bound with limited mobility and are at higher risk of falls, fractures, and rehospitalizations. A recent study by the investigators suggests that backward locomotion treadmill training (BLTT) may be a promising rehabilitative approach in stroke survivors with severe walking impairment; however, the effect of training duration on behavioral outcomes is unknown.

The objective of this study is to obtain critical pilot data on the effects of extended BLTT on walking speed, symmetry, and balance (static and dynamic), in chronic stroke survivors with baseline severe walking impairment, relative to forward treadmill training controls (FLTT).

Aim 1. Determine the training-related effects of extended BLTT on overground walking speed (primary outcome) in survivors with severe walking impairment. To achieve this aim, we will compare the Pre-Post change in walking speed [10- meter walk test (10MWT)] between groups. The working hypothesis is that extended BLTT will increase walking speed to a clinically meaningful level (≥0.16m/s), compared to the control group (FLTT).

Aim 2. Determine the effects of extended BLTT on walking symmetry and balance. The Zeno Walkway Gait Analysis software will capture Pre-Post changes in temporal gait symmetry index during the 10-MWT. Working hypothesis 2a: BLTT will be associated with a favorable improvement in the temporal symmetry index score. Proprioception and spinovestibular function will be measured with the modified Sensorineural Integration Test (mSIT), and dynamic balance will be assessed with the completion time on the instrumented Timed Up & Go (i- TUG). Working hypothesis 2b and c: BLTT will be associated with a favorable improvement Pre-Post mSIT(a) and completion time on the i-TUG (b).

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Ohio
      • Cincinnati, Ohio, United States, 45267
        • Recruiting
        • University of Cincinnati College of Medicine
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 18-80 years of age
  • Walking speed less than or equal to 0.4 meters/second
  • Ability to maintain greater than or equal to 0.3mph speed for 6-minute interval on the treadmill
  • Able to walk independently (cane and hemi-walker acceptable)
  • Ambulate >10 meters over ground with the Free Step Harness System (as a safety precaution)
  • Discharged from formal rehabilitation

Exclusion Criteria:

  • Unstable cardiac status which would preclude participation in a moderate-intensity exercise program.
  • Significant language barrier which might prevent the participant from following instructions during training and testing.
  • Adverse health condition that might affect walking capacity (severe arthritis, significant pulmonary disease significant ataxia, or severe hemi-neglect)
  • Severe lower extremity spasticity (Ashworth >2)
  • Depression (>10 on the Patient Health Questionnaire, if untreated).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Backward Locomotion Treadmill Training (BLTT)
Participants train on a reverse treadmill (no bodyweight support), three times per week x 4 weeks.
12-training sessions of reverse treadmill training (no bodyweight support) over four weeks.
Sham Comparator: Forward Locomotion Treadmill Training (FLTT)
Participants train on a treadmill (no bodyweight support), three times per week x 4 weeks.
12-training sessions of forward treadmill training (no bodyweight support) over tfour weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in 10-Meter Walk (fast)
Time Frame: Pre-Baseline (Day of Randomization) to One Day Post-Training
Two 10MWT trials (using a stop-watch) are averaged and documented in meters/second.
Pre-Baseline (Day of Randomization) to One Day Post-Training

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
10-Meter Walk Test (Fast- Retention)
Time Frame: One Day Post Training, One month Post Training, 3- Months Post Training
Two 10MWT (fast) trials (using a stop-watch) are averaged and documented in meters/second.
One Day Post Training, One month Post Training, 3- Months Post Training
10-Meter Walk (Comfortable)
Time Frame: Baseline (Day of Randomization), One Day Post-Training, One month Post Training, 3-Months Post Training
Two 10MWT trials (using a stop-watch) are averaged and documented in meters/second.
Baseline (Day of Randomization), One Day Post-Training, One month Post Training, 3-Months Post Training

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Static Balance: Sway Index (SI)
Time Frame: Baseline (Day of Randomization), One Day Post-Training, One month Post Training, 3- Months Post Training
The Biodex Modified Clinical Test of Sensory Interaction on Balance (mSIBT) is a well-validated balance system and has been used neurally intact and neurologically impaired individuals to objectively measure static balance. Compared to other measures of static balance, the mSIBT provides the added benefit of differentiating the contributions of the visual, proprioceptive and vestibular systems. Method: While on the platform (with safety harness), participants will stand with the hands at the side under 4 conditions (30 secs/condition):1) firm surface with the eyes open, 2) firm surface with the eyes closed, 3) compliant surface (foam) with the eyes open, 4) Compliant surface (foam) with the eyes closed. Three attempts will be average and documented as SI.
Baseline (Day of Randomization), One Day Post-Training, One month Post Training, 3- Months Post Training
Dynamic Balance: Instrumented Timed Up & Go (i-TUG)- 3 Meter
Time Frame: Baseline, One Day Post-Training, One month Post Training, 3- Months Post Training
Participants will be instructed to sit with the back against the chair (seat height 46cm, arm height 67cm) and on the word "go," stand up, walk at a comfortable speed past the 3-m mark, turn around, walk back, and sit down in the chair. Two trials are averaged and documented in seconds.
Baseline, One Day Post-Training, One month Post Training, 3- Months Post Training
Dynamic Balance: Instrumented Timed Up & Go (i-TUG)- 7 Meter
Time Frame: Baseline, One Day Post-Training, One month Post Training, 3- Months Post Training
Participants will be instructed to sit with the back against the chair (seat height 46cm, arm height 67cm) and on the word "go," stand up, walk at a comfortable speed past the 7-m mark, turn around, walk back, and sit down in the chair. Two trials are averaged and documented in seconds.
Baseline, One Day Post-Training, One month Post Training, 3- Months Post Training
Temporal Symmetry Index
Time Frame: Temporal Symmetry Index
%-limb support of the affected and unaffected leg, during the 10 MWT
Temporal Symmetry Index

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 15, 2020

Primary Completion (Estimated)

December 31, 2023

Study Completion (Estimated)

June 30, 2024

Study Registration Dates

First Submitted

January 19, 2021

First Submitted That Met QC Criteria

January 19, 2021

First Posted (Actual)

January 25, 2021

Study Record Updates

Last Update Posted (Actual)

September 13, 2023

Last Update Submitted That Met QC Criteria

September 11, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Backward Locomotion Treadmill Training (BLTT)

Subscribe